• Addressing Complex Oligonucleotide Therapeutics and Approach Towards Endotoxin Removal  (Video)

Carter Holt, Process Development Supervisor at Axolabs Petaluma, discusses the importance of removing endotoxins from biological solutions at the TIDES USA 2023 conference in San Diego, California. In this interview, Holt highlights the potential points of endotoxin introduction during the manufacturing process and discusses Axolabs’ approaches, including the use of charged filters, SEC chromatography, and ultrafiltration, for efficient endotoxin removal.

• Building an Oligo Manufacturing Partnership with Asahi Kasei Bioprocess and Axolabs (Video)

Thomas Rupp, Managing Director at Axolabs Berlin, and Chris Rombach, Senior Vice President at Asahi Kasei Bioprocess discuss the future of oligonucleotide therapeutics and the challenges associated with large-scale manufacturing while at TIDES 2023 in San Diego, California.